Distal Ulna Giant Cell Tumor Resection with Reconstruction Using Distal Ulna Prosthesis and Brachioradialis Wrap Soft Tissue Stabilization

Burke, Charity S.; Gupta, Amit; Buecker, Peter J.

doi:10.1007/s11552-009-9192-9

Cited by 24 publications

(24 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The treatment options should always consider oncological radicality of the tumour and the restoration of functionality [15]- [17]. In the present case scenario intralesional curettage was possible as the tumour was a grade II lesion and the reconstruction was carried out with augmentation of bone cement with autologous cortico-cancellous bone graft from maternal iliac crest as the child is young.…”

Section: Discussionmentioning

confidence: 91%

Osteoclastoma of Proximal Ulna―Atypical Location in a 13-Year-Old Child

Patil¹,

Yalamanchili²

2014

OJO

View full text Add to dashboard Cite

Giant cell tumour (GCT) or osteoclastoma is a very rare locally invasive bone tumour that occurs close to the joint. The ulnar metaphysis is an unusual site for an Osteoclastoma with occurrence rate of 0.45% to 3.2% as reported in literature [1]. Most of the patients seek traditional methods of treatment before orthopaedic consultation and present lately with extensive involvement of the tumour into soft tissues and articular surface, making the joint preservation difficult or impossible. For reconstruction, several options have been described, which include fibular autografts, allografts and cement augmentation. Inherent to all these procedures is the risk of delayed union of the graft and preserving functional mobility of the joint. We report a rare case of a proximal ulna GCT diagnosed in a 13-year-old girl. It was treated with intralesional curettage, and autologous maternal iliac crest bone grafting augmented with bone cement reconstruction.

show abstract

Section: Discussionmentioning

confidence: 91%

Osteoclastoma of Proximal Ulna―Atypical Location in a 13-Year-Old Child

Patil¹,

Yalamanchili²

2014

OJO

View full text Add to dashboard Cite

show abstract

“…According to Schajowicz [11] , curettage alone is an inadequate oncological procedure, but when it is combined with an adjuvant therapy, it globally provides a better result with respect to one-block excision, especially in terms of functionality. Therefore, the correct treatment must achieve a balance between oncological radicality and the restoration of skeletal segment functionality [12][13][14] . Curettage associated with bone grafting has been shown to be effective in many cases [15] .…”

Section: Discussionmentioning

confidence: 99%

Giant Cell Tumour of the Distal Ulna: A Case Report

Bansal¹

2018

jmscr

View full text Add to dashboard Cite

“…The overall risk for metastatic spread ranges from 1% to 9%, with the largest series reporting a rate of 2.6%. 26,27 Mortality from lung metastases in GCTs range from 14% to 23%. 26,28,29 We observed lung metastases in 15% of benign GCTs.…”

Section: Discussionmentioning

confidence: 99%

Giant cell tumour of bone: A demographic study from a tumour unit in South Africa

Zanati¹,

Ferreira²,

Marais³

2016

SA orthop. j.

View full text Add to dashboard Cite

Introduction: Giant cell tumour of bone (GCT) is a rare primary bone tumour. Little is known about the epidemiology of this tumour in South Africa as most demographic information is based on research from Asia, Europe and North America. This research aims to raise awareness and promote early recognition of these tumours. Materials and methods: A retrospective analysis was conducted of all patients with biopsy-confirmed GCTs that presented between January 2010 and December 2014. Information pertaining to patient demographics, tumour location, treatment and outcome was recorded and analysed. Results: Twenty-two patients were included in the study. The mean age of patients was 32.4 years (range 12-63), and a slight male predominance (1.2:1) was observed. Tumours were mainly located at the end of long bones (91%) with the distal femur and proximal tibia being most commonly affected (55%). Two patients (9%) were diagnosed with primary malignant giant cell tumours. We observed a higher rate of lung metastases (18%) than previously reported. The median tumour volume was significantly higher in patients who developed lung metastases (467.4 cm 3 vs 137.8 cm 3 ; p=0.03). Three of the patients with lung metastases were HIV-positive (odds ratio [OR] = 10.5, 95% confidence interval [CI] = 0.84-130.66, p=0.076). All patients were treated surgically with extended curettage, local adjuvant therapy, polymethyl methacrylate (PMMA) and internal fixation or en-bloc resection with prosthetic or osteochondral allograft replacement. Conclusion: Giant cell tumours of bone are uncommon. Demographics from South Africa emulate international statistics. No recurrence of GCTs was observed in our cohort despite the relatively large tumours at time of presentation compared to international literature that report recurrence rates of approximately 2%. The incidence of metastases and primary malignant GCT was higher than in previous reports. The association of these findings with HIV infection warrants further investigation. Metastases appear to be associated with the size of the primary tumour.

show abstract

Distal Ulna Giant Cell Tumor Resection with Reconstruction Using Distal Ulna Prosthesis and Brachioradialis Wrap Soft Tissue Stabilization

Cited by 24 publications

References 14 publications

Osteoclastoma of Proximal Ulna―Atypical Location in a 13-Year-Old Child

Osteoclastoma of Proximal Ulna―Atypical Location in a 13-Year-Old Child

Giant Cell Tumour of the Distal Ulna: A Case Report

Giant cell tumour of bone: A demographic study from a tumour unit in South Africa

Contact Info

Product

Resources

About